Inhalation Capsules Market Outlook:
Inhalation Capsules Market size was over USD 1.06 billion in 2025 and is poised to exceed USD 2.18 billion by 2035, witnessing over 7.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of inhalation capsules is estimated at USD 1.13 billion.
The inhalation capsules market has triggered the use of inhalation capsules so that they start working immediately. Inhalation has the advantage of allowing the medicine to be delivered directly into the bloodstream without having to go through digestion, as would be the case with oral medications. This results in a quicker therapeutic response and explains why inhalation capsules are ideal if a quick reaction is needed, for instance, in emergency treatments or managing acute manifestations. NIH, the National Institute of Health/National Library of Medicine, states that the hard gelatin capsules have been successfully used in inhalation capsules, also known as dry powder inhalers (DPI), for more than 30 years already, which makes them the standard choice for DPI development, given the amount of data available on their use. These are strong products and have worked greatly when their moisture content was within the specification of 13% to 16%.
